Thousands of EOHN clinics incorporate our eReader, eCCF® paperless process, and more.
Drugs of Abuse Screening
Become a clinic partner for collections
eScreen has partnered with thousands of occupational health clinics, emergency rooms, hospitals, and urgent care centers to form the EOHN™ occupational health network. When you join the eScreen network, your staff will be trained and certified on how to use our computerized drugs of abuse screening system—the eScreen123® test management software. This system guides your staff through a step-by-step process to ensure your clinic always delivers secure and confidential employee drug-testing collections.
The eScreen123 system directs your clinic in completing:
- Rapid, lab-based urine collections
- Breath alcohol collections
- Physical examinations
A significant difference between our system and those of our competitors is our eCup® test device and eReader® analyzer—the industry's first computerized drug-screening technology. Our "walk-away" testing technology means you no longer handle or aliquot urine. In addition, our drug test system is paperless and allows for rapid drug screens.
Want specifics? Click on the links below.
Our eScreen123 web-based software program is a wizard-driven system that ensures your clinic performs consistent, efficient DOT (Department of Transportation) and non-DOT employee drug testing collections. By incorporating customer-specific processes, the system presents clinic staff with the proper tests and correct exception procedures.
For all non-DOT testing events, our system creates an electronic chain-of-custody form via our eCCF® paperless process, which begins at the time of the collection. The eCCF paperless system comes complete with digital signatures of both the donor and the collector. This feature eliminates the expense and delays that are typically associated with incomplete paper forms and the faxing/mailing of paper chains.
- Provides consistent collection procedures.
- Helps minimize collection errors.
- Captures data and statistics for reports.
- Manages services for both DOT- and non-regulated programs.
The eCup test device, along with the eReader screening system, creates the industry’s first digitally interpreted non-DOT rapid testing system. The patented eCup urine collection device allows for rapid, under-seal screening. A major advantage to our “smart” cup is that it doesn’t require human intervention or interpretation, which means there’s no chance for human error.
How does the eCup device work? Once the donor provides his or her urine specimen into the plastic cup, the lid is attached and sealed. The self-contained unit keeps the clinician from having to pour, transfer or pipette the specimen into any other container. Instead, the cup—in combination with our patented eReader appliance—does all the work.
The uniquely designed eCup lid contains several embedded reagent test strips that are sensitive to the five-test SAMHSA (Substance Abuse and Mental Health Services Administration) profile cutoff levels, as well as adulteration panels for pH, creatinine, and nitrites.
When the eCup device is placed into the eReader system, its test strips are digitally screened for the presence or absence of drugs of abuse. The result? Rapid drug test results for all negative drug screens are sent directly to your customer.
The eReader screening system is a sophisticated appliance that uses digital technology to scan the test lid of a sealed eCup device. This automated procedure provides an objective and confidential testing process. Using bar code technology coupled with optical imaging, the eReader system electronically captures the drug test results, thereby eliminating clinician subjectivity. Within 15 minutes, the eReader automatically reports negative eCup urine drug screen results to the customer’s MyeScreen® software account (or other applicant-tracking system).
For non-negative samples the clinician packages the drug screen sample with the chain-of-custody form and ships it to the laboratory for confirmation testing.
The mCup drug test device is a manually-interpreted urine drug screen cup. Offered in test panels of 5, 7, 9 10, and 11, the mCup device works in conjunction with our software, electronic chain of custody forms, and automated result reporting solution. Learn more about our premiere urine testing options.
Lab-based urine testing allows for all panel options. The sample is collected at the point of service and then processed through the eScreen system. All non-DOT tests are performed using our eCCF® paperless process and automated results reporting. The system also coordinates the collection, paper federal form completion, and shipment of all DOT tests—while reporting these test results to the employer online. Learn more about our premiere urine testing options.
Our eCCF® paperless process reduces costs and administrative functions by eliminating the need for paper chain of custody forms. Electronic forms minimize errors during collection, ensure consistency of procedures, and link all parts of the donor-screening process.
The eCCF solution incorporates security technologies that protect all aspects of the electronic signature: capture, presentation, validation, and storage. In fact, our security protocol ensures that all electronic data is nonrefutable, legally valid, and has a defensible audit trail.
As an additional layer of authentication, our system adds an auditable time stamp as it embeds the electronic signatures with the eCCF document.
We provide a truly paperless process. You no longer face time-consuming, post-analytic work. No more data entry or transcription of test details. No faxing. And no manual record-keeping.
In fact, you never have to print the chain unless you need to send the specimen to the laboratory or the donor requests a copy of the paperwork.
In addition to drug screening, our eScreen123 application also allows you to process and manage a variety of other events including breath alcohol tests, hair drug testing, DNA screening, physical exams, and occupational health services. Collections and screenings become data that are “re-creatable events,” creating sample integrity, increased confidentiality and protocol consistency for the donor and your clinic.